Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 天美传媒 Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Oral L-arginine supplements have been tried to lower blood pressure with conflicting results, with one of the
factors affecting the outcome is whether the subject is healthy or has hypertension. Arginine is a substrate
for at least four enzymes including nitric oxide synthase and arginase, but the impact of oral supplements on its
different metabolic pathways is not clear. We examined the effect of L-arginine and D-arginine, at two different
doses of 500 mg/kg/d (500) or 1000 mg/kg/d (1000) in drinking water administered for 4, 12 or 16 weeks to separate
groups of 9 week old male Sprague-Dawley (SD) rats or 5 week old male Zucker Diabetic Fatty (ZDF) rats. We
report the effects on the endothelial nitric oxide synthase (eNOS)/nitric oxide (NO) and the arginase/urea metabolic
pathways. L-arginine (500) increased eNOS expression in the aorta and the kidney and plasma nitrite levels, but
did not affect the mean arterial pressure (MAP) in the SD rats. L-arginine (500) also decreased arginase II in the
ileum. D-arginine also unexpectedly increased eNOS expression in the kidney and decreased arginase in the liver
and the ileum. Arginine (1000) also did not affect the MAP in the SD rats. On the other hand, L-arginine (1000)
attenuated the increase in MAP in the ZDF rats without affecting eNOS expression or nitrite levels. However, it did
not attenuate the increased arginase expression or urea levels in the ZDF rats as compared to Zucker lean rats. In
conclusion, two different doses and durations of oral arginine treatment did not affect the MAP in Sprague-Dawley
rats, but attenuated it in the ZDF rats. Thus, the blood pressure lowering effect of oral L-arginine should not be taken
for granted and their effects on the arginase and other metabolic pathways (results not shown) should be considered
to avoid adverse effects.
Biography
Sarah Martin has completed her BSc in Physiology and Pharmacology at the University of Saskatchewan. Her project aimed to study the effects of oral arginine supplements on male Sprague-Dawley and Zucker Diabetic Fatty rats. She is pursuing her MSc and is excited to start the Post Degree Nursing program next spring with the final goal of becoming a nurse practitioner.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, 天美传媒 Access Journals